Associate Director / Director, Accounting and SEC Reporting

Full-timeExecutiveG&ACardiovascular
$150K - $213K/yr(employer-provided)

Description

Role Summary  Reporting to Lexeo’s Vice President and Corporate Controller, the Director, Accounting, will be responsible for the overall accounting and SEC reporting activities of the Company in addition to driving process improvements and support of accounting policies, procedures and internal controls. This hands-on role will oversee a team of two, execute day-to-day accounting functions, and produce high-quality SEC reporting while ensuring the application of best practices and compliance with all policies and internal controls. 

About Lexeo 

Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.    

Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home. 

LEXEO Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment. 

Like this job? Get alerts for similar ones

We'll notify you when matching roles are posted.

CardiovascularG&ANew York, New York
Lexeo Therapeutics

Lexeo Therapeutics

BIOTECHNOLOGY

Gene Therapy

LocationNY - New York
Open Jobs10

Pipeline

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients WiN/A
Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 PN/A
Clinical Course Of Disease In Participants With FA-CMN/A
LX1001Phase 1
LX1001Phase 1/2